ScholarLens Back to search
1992•Lara D. VeekenRequires access

PREVENTION OF BLINDNESS IN GIANT CELL ARTERITIS BY CORTICOSTEROID TREATMENT

A B Myles, M. Thamara P. R. Perera, M G Ridley

Open publisher page 66 citations

Abstract

Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started. Those starting on 20 mg of prednisolone or less daily fared at least as well as those starting on higher doses. Analysis of the literature does not support the belief that higher doses provide greater protection from blindness.

About this research paper

What this paper is about

Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started. Those starting on 20 mg of prednisolone or less daily fared at least as well as those starting on higher doses. Analysis of the literature does not support the belief that higher doses provide greater protection from blindness.

Why it matters

OpenAlex reports 66 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started. Those starting on 20 mg of prednisolone or less daily fared at least as well as those starting on higher doses. Analysis of the literature does not support the belief that higher doses provide greater protection from blindness.

Key concepts: Medicine, Giant cell arteritis, Blindness, Corticosteroid, Arteritis, Dermatology, Vasculitis, Surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
PREVENTION OF BLINDNESS IN GIANT CELL ARTERITIS BY CORTICOSTEROID TREATMENT — Research Paper | ScholarLens